References
- Chapman RH, Benner JS, Petrilla AA, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med 2005;165:1147-52
- Elliott WJ, Plauschinat CA, Skrepnek GH, et al. Persistence, adherence and risk of discontinuation with commonly prescribed antihypertensive drug monotherapies. Jam Board Fam Med 2007;20:72-80
- Simons LA, Ortiz M, Calcino G. Persistence with antihypertensive medication: Australia wide experience. Med J Aust 2008;188:224-7
- Yeaw J, Benner JS, Walt JG, et al. Comparing adherence and persistence across six chronic medication classes. J Manag Care Pharm 2009;15:728-40
- Simons LA, Ortiz M, Calcino G. Long term persistence with statin therapy – experience in Australia 2006–2010. Aust Fam Physician 2011;40:319-22
- Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97
- Gupta AK, Arshad S, Poulter NR. Compliance, safety and effectiveness of fixed dose combinations of antihypertensive agents. A meta-analysis. Hypertension 2010;55:399-407
- Simons LA, Ortiz M, Calcino G. Persistence with a single pill versus two pills of amlodipine and atorvastatin: the Australian experience. Med J Aust 2011;195:134-7
- Grimmsmann T, Himmel W. Comparison of therapy persistence for fixed versus free combination antihypertensives: a retrospective cohort study. BMJ Open 2016;6:e011650
- Nelson MR, Reid CM, Ryan P, et al. Self-reported adherence with medication and cardiovascular disease outcomes in the second Australian National Blood Pressure Study (ANBP2). Med J Aust 2006;185:487-9
- Ortiz M, Calcino G. Differences in persistence when calcium channel blockers are combined with angiotensin converting enzyme (ACE) inhibitors (Abstr). Hypertension 2010;55:1506
- Calcino G, Ortiz M. Differences in persistence when calcium channel blockers are combined with angiotensin II receptor antagonists (Abstr). Hypertension 2010;55:1506
- Sandberg A, Kostev B, Ehiken B, et al. Persistence and compliance in hypertensive patients treated with fixed or unfixed combinations of angiotensin receptor blockers, amlodipine and hydrochlorothiazide (Abstr). Value Health 2011;14:A43
- Simonyi G, Ferenci T, Alfoldi S, Farsang C. Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence. J Int Med Res 2016;44:1087-91
- Simonyi G, Ferenci T, Medvegy M. Persistence of fixed and free combination of perindopril and amlodipine in hypertension (Abstr). Eur Heart J 2016;37(Suppl):213
- Ortiz M, Calcino G. Inferred mortality differences between dihydropyridine antihypertensives (Abstr). Hypertension 2009;53:1116